Ocular neuromyotonia is characterized by paroxysms of tonic contraction of 1 or more of the extraocular muscles, usually consequent to radiation.1,2 We describe a unique example of ocular neuromyotonia from nonirradiated, stroke-related intramedullary lesions of the midbrain and thalamus.
A healthy 41-year-old man lapsed into a coma after developing sudden dizziness, sweating, and diplopia. Magnetic resonance imaging (Figure) showed high signal intensity on T2-weighted images at the left mesodiencephalic junction involving the left red nucleus and third nerve extending superiorly to the left centromedian thalamus, a punctate focus of susceptibility at the root exit zone of the left third nerve and a small area of abnormal signal at the right mesodiencephalic junction. The lesions were consistent with hemorrhage and infarction. The patient was presumed to have suffered a stroke. He improved but had residual diplopia, a “clumsy” right arm, and gait ataxia.
Magnetic resonance images of the brain. A, Axial T2-weighted image showing high signal intensity (arrow) at the left mesodiencephalic junction. B, Axial T2-weighted image showing bilateral signal elevation (arrows) in the centromedian thalami and an incidentally noted left insular developmental venous anomaly (arrowhead). C, Axial gradient echo image showing focus of susceptibility (arrow) along the course of the left third nerve.
Three months after the onset, there was bilateral lid retraction, slow elevation and depression of both eyes, and limited elevation and depression of the left eye. His pupils were unremarkable. Two days later, the patient reported that he had developed about 30 episodes daily of vertical diplopia, each heralded by transient right periorbital tingling. His right eye would deviate down and in for up to 3 minutes. Tingling would recur, and the eye would return to a normal position. There was no oscillopsia. Observation of several episodes during re-examination several days later confirmed his description. Carbamazepine abolished the episodes. Three months later, he had full ductions, but elevation and depression of both eyes were slow. On all refixations, both eyes would make a slow, conjugate, small-amplitude clockwise rotation and then a corrective movement before stabilizing. At present, he is still receiving carbamazepine.
Ocular neuromyotonia affects the extraocular muscles either individually or in combination, causing episodic diplopia that develops either spontaneously or after gaze in the direction of action of the affected muscle. Electromyography suggests a neurogenic basis for the movements.3,4 The tonic contractions are thought to result from the spontaneous discharge of unstable neurons, which are transmitted to adjacent neurons by ephaptic transmission. Consistent with the theory of axonal instability, membrane-stabilizing agents such as carbamazepine are effective.
To our knowledge, this is the first report of a patient whose ocular neuromyotonia was caused by a stroke, as well as the first in which the responsible lesion was intramedullary. Our patient’s lesions were predominantly contralateral to the side of his neuromyotonia, with only 1 small lesion at the ipsilateral mesodiencephalic junction. While we cannot determine which, if any, of his lesions caused the neuromyotonia of his right eye, we note that his lesions spared the nuclei and intramedullary fascicles of the right third nerve. We conclude that ocular neuromyotonia can result from purely intramedullary lesions, without the involvement of the lower motor neuron.
Correspondence: Dr Lessell, Massachusetts Eye and Ear Infirmary, 243 Charles St, Boston, MA 02114 (firstname.lastname@example.org).
Financial Disclosure: None.
Funding/Support: Manuscript development was supported in part by grant G12-RR03026-15 from the National Center for Research Resources, Bethesda, Md.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Thank you for submitting a comment on this article. It will be reviewed by JAMA Ophthalmology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 6
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.